Send us a link
Two Major California Research Institutes Will Merge
Scripps and Calibr set to join forces
Keep Politics Out of Science?
Taking potshots at some scientific research is a pastime of American politics. But critics need to assess the merits of the research they target beforehand.
Science Group Seeks to Guide Silicon Valley Philanthropists
Uncertain government funding drives effort to beef up private support for research
Grading the Presidential Candidates on Science
Scientific American evaluates responses from Clinton, Trump, Johnson and Stein to 20 questions
Facebook Couple Commits $3 Billion to Cure Disease
Chan Zuckerberg Initiative aims to have major impact by 2100.
Biden’s Moonshot Cancer Plan Calls for More Data Sharing
New report describes steps to double progress in 5 years
President Obama Pushes Innovation ‘Frontiers’ in STEM
More than $300M in new STEM initiatives were announced at the White House Frontiers Conference.
Harnessing the Possibilities of Science, Technology, and Innovation
President Obama Hosts Frontiers Conference, Focusing on the Potential of Science, Technology, and Innovation to Drive Prosperity and Address Challenges in Personal, Local, National, Global, and Interplanetary Frontiers for the Next 50 Years and Beyond.
Business Backs the Basics
Long-term basic research, substantially funded by the U.S. government, underlies some of industry's most profitable innovations.
Free to Collaborate with Cuban Biomedical Researchers
New rules also loosen restrictions on Cuban-made pharmaceuticals.
The Administration’s Report on the Future of AI
A new report from the US Administration focuses on the opportunities, considerations, and challenges of Artificial Intelligence (AI).
The boldness of philanthropists
Last week, Priscilla Chan and Mark Zuckerberg announced their new philanthropic initiative with the goal of “curing, preventing, and managing all diseases by the end of the century.” This may raise some eyebrows, but this effort—part of the $45 billion Chan Zuckerberg Initiative—joins forces with other philanthropists to push the envelope and support audacious ideas, with long-term commitments, to solve some of our greatest challenges.
Tougher rules for clinical-trial transparency
Investigators are now required to disclose all clinical trials, whether successful or not.
NIH aims to beef up clinical trial design
NIH wants to expand the sharing of summary data from clinical trials, such as test results being reviewed here at NIH’s clinical center.
Clinical trial rules aim to improve public reporting of results
Researchers will have to publicly report the results of many more clinical trials under new government rules announced Friday.